Trials / Completed
CompletedNCT00392262
A Study to Evaluate the Combination of Valsartan + Amlodipine in Hypertensive Patients
An Multicenter Study to Evaluate the Efficacy and Tolerability of a 4-week Therapy With the Combination of Valsartan 160mg + Amlodipine 5mg in Hypertensive Patients Not Adequately Responding to 4-week Treatment With Amlo 5mg or Felodipine 5mg in Monotherapy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 224 (actual)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The purpose of this study is to evaluate the efficacy of valsartan plus amlodipine in hypertensive patients not responding to treatment with amlodipine or felodipine alone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | valsartan + amlodipine |
Timeline
- Start date
- 2006-08-01
- Primary completion
- 2007-02-01
- Completion
- 2007-02-01
- First posted
- 2006-10-25
- Last updated
- 2016-11-18
Locations
2 sites across 2 countries: Germany, Switzerland
Source: ClinicalTrials.gov record NCT00392262. Inclusion in this directory is not an endorsement.